Health and well-being have no borders. Therefore GEYMONAT has decided to invest many resources to start a broad internationalization programme of licencing out. The production experience and reliability led Geymonat to make licence and distribution agreements for its own products in about 40 countries  GEYMONAT believes in synergies for mutual benefit and is therefore member of the: Consortium COPHITAL (Algeria). A similar grouping is being organized in Morocco as well.
GEYMONAT has also played a major role in the foundation of a free international association PHARMA-CLUB and of its consociated SALUC PHARMA S.A., holding for e.g. licensing rights for the anti-histaminic emedastine in Europe(where relative authorization is pending at the MEDICINE CONTROL AGENCY in UK), Latin America, and some Middle-East countries